Policy & Ethics

Where science meets society: regulatory decisions, research ethics, public health policy, and the debates around how scientific knowledge is applied, funded, and communicated.

A Litigation Boom Over Roundup
Medical panic often begins with the aesthetics of mathematics. It arrives coated in charts, percentages, thresholds, risk scores, and trend lines, all carrying the aura of objectivity and rigor.
The government’s misguided attempt to address the opioid overdoses did more than change prescribing practices. It changed the relationship between doctors and patients, and not for the better.
In a recent Cato blog post, I discussed several factors that may be contributing to the current and welcome drop in overdose deaths.
The Centers for Disease Control and Prevention (CDC) recently reported that overdose deaths during the 12-month period ending in December 2025 declined by 13.9
For many years, the medical establishment has argued, and in my view correctly, that addiction is a legitimate neurobiological condition that may often require long-term pharmacologic treatment, including with an opioid such as buprenorphine or me
In complex systems, intermediaries can “grease the wheels” by lowering transaction costs, streamlining logistics, and bridging information gaps.